Browser & Computer Use comparison

Best Open-Source Browser & Computer Use: Skyvern vs Stagehand

A data-backed comparison of the top two browser & computer use on HVTracker, built from public trust signals rather than stars alone.

June 4, 2026 · 4 min read · Data updated 2026-06-04 18:04 UTC

Short answer: Skyvern currently leads Stagehand on HVTracker's evidence-weighted trust score: 88.5 vs 88.1/100. This is not a popularity ranking; it combines supply-chain safety, identity/provenance, transparency, maintenance, and adoption signals.

Skyvern

88.5
#19 overall · #1 in Browser & Computer Use · Grade A

Automate browser based workflows with AI

RepositorySkyvern-AI/skyvern
Stars21.8k
Last push2026-06-04
Weekly commits390
Weekly downloads2,202

Stagehand

88.1
#21 overall · #2 in Browser & Computer Use · Grade A

The SDK For Browser Agents

Repositorybrowserbase/stagehand
Stars22.9k
Last push2026-06-04
Weekly commits57
Weekly downloads1,015,673

Skyvern vs Stagehand: trust signal breakdown

Both projects are tracked in the Browser & Computer Use category, but they do not expose the same evidence. The table below compares the public signals that feed HVTrust.

SignalSkyvernStagehand
HVTrust score88.588.1
Safety / Integrity21.2/3019.4/30
Identity / Provenance18.0/2018.0/20
Transparency14.4/2013.2/20
Maintenance20.0/2019.0/20
Adoption14.9/1018.5/10
OSSF Scorecard7.05.5
Signed commits100%100%
Package provenanceVerifiedVerified

Which one should you evaluate first?

If your priority is the most verifiable trust profile today, start with Skyvern. It has the stronger current HVTrust score and ranks higher in Browser & Computer Use. If your use case depends on a specific runtime, language, license, or integration model, use the individual profiles rather than the headline score alone.

For production use, the practical checklist is: inspect the security policy, confirm package provenance or release signing where available, review recent maintenance cadence, and compare the exact trust breakdown. HVTracker is meant to reduce the first-pass research burden, not replace your own risk review.